Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Dybly AG
DescriptionPan-BET bromodomain inhibitor
Molecular Target Bromodomain containing 2 (BRD2)
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today